Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase

Farnesyltransferase inhibitors (FTIs) are focus for the treatment of several diseases, particularly in the field of cancer therapy. Their potential, however, goes even further, as a number of studies have evaluated FTIs for the treatment of infectious diseases such as malaria, African sleeping sickn...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Lea, Hagemann, Anna, Kaltenhäuser, Jila, Besser, Manuela, Rockenfeller, Patrick, Ehrhardt, Anja, Stuermer, Ewa, Bachmann, Hagen Sjard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669142/
https://www.ncbi.nlm.nih.gov/pubmed/34917041
http://dx.doi.org/10.3389/fmicb.2021.628283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669142/
https://www.ncbi.nlm.nih.gov/pubmed/34917041
http://dx.doi.org/10.3389/fmicb.2021.628283

Ejemplares similares